These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 8228534)
1. Continuous flow perfusion of gentamicin with a scleral shell reduces bacterial colony counts in experimental Pseudomonas keratitis. Rootman DS; Krajden M J Ocul Pharmacol; 1993; 9(3):271-6. PubMed ID: 8228534 [TBL] [Abstract][Full Text] [Related]
2. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy. Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of topical gentamicin treatment after 193-nm photorefractive keratectomy in an experimental Pseudomonas keratitis model. Frucht-Pery J; Golan G; Hemo I; Zauberman H; Shapiro M Graefes Arch Clin Exp Ophthalmol; 1995 Aug; 233(8):532-4. PubMed ID: 8537030 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Silbiger J; Stern GA Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778 [TBL] [Abstract][Full Text] [Related]
5. Iontophoretic treatment of experimental pseudomonas keratitis in rabbit eyes using gentamicin-loaded hydrogels. Frucht-Pery J; Raiskup F; Mechoulam H; Shapiro M; Eljarrat-Binstock E; Domb A Cornea; 2006 Dec; 25(10):1182-6. PubMed ID: 17172895 [TBL] [Abstract][Full Text] [Related]
6. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
7. Fortified antibiotic ointment in bacterial keratitis. Hyndiuk RA; Skorich DN; Davis SD; Sarff LD; Divine K; Burd E Am J Ophthalmol; 1988 Mar; 105(3):239-43. PubMed ID: 3125745 [TBL] [Abstract][Full Text] [Related]
10. Zymar (Gatifloxacin 0.3%) shows excellent Gram-negative activity against Serratia marcescens and Pseudomonas aeruginosa in a New Zealand White rabbit keratitis model. Mah FS; Romanowski EG; Kowalski RP; Yates KA; Gordon YJ Cornea; 2007 Jun; 26(5):585-8. PubMed ID: 17525656 [TBL] [Abstract][Full Text] [Related]
11. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models. Kowalski RP; Romanowski EG; Mah FS; Shanks RM; Gordon YJ Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251 [TBL] [Abstract][Full Text] [Related]
12. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131 [TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy of topical moxifloxacin versus ciprofloxacin and vancomycin in the treatment of P. aeruginosa and ciprofloxacin-resistant MRSA keratitis in rabbits. Aliprandis E; Ciralsky J; Lai H; Herling I; Katz HR Cornea; 2005 Mar; 24(2):201-5. PubMed ID: 15725889 [TBL] [Abstract][Full Text] [Related]